Stuart Rich
#139,366
Most Influential Person Now
Researcher
Stuart Rich's AcademicInfluence.com Rankings
Stuart Richengineering Degrees
Engineering
#5139
World Rank
#6383
Historical Rank
Electrical Engineering
#1394
World Rank
#1487
Historical Rank

Stuart Richcomputer-science Degrees
Computer Science
#6593
World Rank
#6951
Historical Rank
Computational Linguistics
#1173
World Rank
#1187
Historical Rank
Machine Learning
#2196
World Rank
#2224
Historical Rank
Artificial Intelligence
#2463
World Rank
#2504
Historical Rank

Download Badge
Engineering Computer Science
Stuart Rich's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Stuart Rich Influential?
(Suggest an Edit or Addition)Stuart Rich's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. (1996) (2445)
- Primary pulmonary hypertension. A national prospective study. (1987) (2023)
- The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. (1992) (1475)
- Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. (2002) (1365)
- Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy (2002) (1225)
- Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease (2000) (1084)
- Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. (1996) (850)
- Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. (1998) (674)
- Beraprost therapy for pulmonary arterial hypertension. (2003) (608)
- Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. (1996) (522)
- Clinical classification of pulmonary hypertension. (2001) (508)
- Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. (1989) (455)
- A USA-based registry for pulmonary arterial hypertension: 1982–2006 (2007) (438)
- Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. (2001) (427)
- International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). (1998) (392)
- Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation (2009) (388)
- High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. (1987) (378)
- Pulmonary arterial hypertension: epidemiology and registries. (2013) (376)
- Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". (2000) (375)
- The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. (1998) (363)
- Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. (2008) (354)
- Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. (2011) (317)
- Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension (1997) (313)
- Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. (1995) (305)
- Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction (2011) (279)
- Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. (2002) (251)
- Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. (2004) (238)
- Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension (2003) (229)
- Endothelin Receptor Blockers in Cardiovascular Disease (2003) (213)
- Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results. (2017) (210)
- Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series (1999) (205)
- Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension (2012) (192)
- Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. (2000) (189)
- The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. (1999) (186)
- Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. (2014) (181)
- Doppler echocardiography assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension (1986) (178)
- Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. (1995) (178)
- Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. (2008) (171)
- Utility of electron beam computed tomography to stratify patients presenting to the emergency room with chest pain. (1999) (159)
- Antinuclear antibodies in primary pulmonary hypertension. (1986) (154)
- Reproducibility of the measurement of coronary calcium with ultrafast computed tomography. (1995) (152)
- Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiography. (1982) (151)
- Primary pulmonary hypertension (1988) (149)
- Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension (2006) (148)
- Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. (1983) (143)
- Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. (1990) (136)
- Appetite-suppressant drugs and the risk of primary pulmonary hypertension (1997) (135)
- Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. (1985) (129)
- Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. (2011) (123)
- Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension. (2010) (123)
- Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed. (2010) (120)
- Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure (1989) (117)
- Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. (1992) (114)
- Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography. (1995) (112)
- The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. (1985) (111)
- Comparison of the effects of adenosine and nifedipine in pulmonary hypertension. (1992) (111)
- Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension (2008) (110)
- Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension. (1984) (108)
- Pulmonary hypertension from chronic pulmonary thromboembolism. (1988) (107)
- Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. (1997) (103)
- Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension. (2005) (99)
- Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. (1997) (97)
- Clinical Diagnosis of Pulmonary Hypertension (2014) (94)
- Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. (1995) (92)
- Uncertainties in the Diagnosis and Treatment of Pulmonary Arterial Hypertension (2008) (92)
- Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. (1995) (90)
- Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. (1983) (89)
- Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. (1986) (89)
- Temporal trends and drug exposures in pulmonary hypertension: an American experience. (2006) (89)
- Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. (2004) (86)
- The current treatment of pulmonary arterial hypertension: time to redefine success. (2006) (86)
- Clinical assessment of heart chamber size and valve motion during cardiopulmonary resuscitation by two-dimensional echocardiography. (1981) (85)
- High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing. (1991) (85)
- Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension. (1986) (82)
- Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. (2002) (80)
- The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. (1990) (77)
- Contemporary Survival in Patients with Pulmonary Arterial Hypertension: A Reappraisal of the National Institutes of Health Risk Stratification Equation (2009) (74)
- Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. (2008) (72)
- Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension (2015) (71)
- [Pulmonary arterial hypertension: epidemiology and registries]. (2014) (70)
- Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. (2016) (68)
- Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. (2010) (67)
- The prevalence and significance of a patent foramen ovale in pulmonary hypertension. (1993) (63)
- Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. (2003) (63)
- Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment. (1989) (61)
- Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. (2017) (60)
- Increased prevalence of significant coronary artery calcification in patients with diabetes. (2001) (59)
- Noninvasive cardiac output measurements in patients with pulmonary hypertension (2012) (58)
- Stenting to reverse left ventricular ischemia due to left main coronary artery compression in primary pulmonary hypertension. (2001) (55)
- Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. (2002) (54)
- Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system. (2012) (53)
- Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome (2017) (53)
- Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment. (1982) (53)
- The International Primary Pulmonary Hypertension Study (IPPHS). (1994) (51)
- Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension. (1983) (51)
- Clinical insights into the pathogenesis of primary pulmonary hypertension. (1998) (50)
- Development of Atherosclerosis in Genetically Hyperlipidemic Rabbits during Chronic Fish‐oil Ingestion (1989) (47)
- Thromboxane synthetase inhibition in primary pulmonary hypertension. (1987) (46)
- The WHO classification of pulmonary hypertension: A case-based imaging compendium (2012) (45)
- Right ventricular adaptation and maladaptation in chronic pulmonary arterial hypertension. (2012) (45)
- Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension. (1993) (44)
- Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension. (2009) (43)
- Value of Exercise Treadmill Testing in the Risk Stratification of Patients With Pulmonary Hypertension (2009) (43)
- Reproducibility of left ventricular myocardial volume and mass measurements by ultrafast computed tomography. (1991) (43)
- Detection of subclinical cardiovascular disease: the emerging role of electron beam computed tomography. (2002) (42)
- Determination of left ventricular ejection fraction using ultrafast computed tomography. (1986) (42)
- Severe pulmonary hypertension associated with COPD. (2000) (40)
- Analysis of regional pulmonary enhancement in dogs by ultrafast computed tomography. (1992) (40)
- Textbook of Pulmonary Vascular Disease (2009) (39)
- Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension (2012) (36)
- The 6-minute walk test as a primary endpoint in clinical trials for pulmonary hypertension. (2012) (35)
- The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II Survey. (1989) (35)
- A Double‐Blind Comparison of Lisinopril with Captopril in Patients with Symptomatic Congestive Heart Failure (1987) (35)
- Medical treatment of primary pulmonary hypertension: a bridge to transplantation? (1995) (33)
- Timing of single lung transplantation for primary pulmonary hypertension. (1994) (32)
- Survival in Patients with Primary Pulmonary Hypertension (2020) (32)
- The value of approved therapies for pulmonary arterial hypertension. (2007) (30)
- Successful management of labor and delivery in primary pulmonary hypertension. (1993) (29)
- Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial. (2021) (29)
- 26. Pulmonary Hypertension Associated with Hepatic Cirrhosis (1990) (26)
- Pulmonary hypertension--advances in medical and surgical interventions. (1998) (26)
- Exercise ultrafast computed tomography for the detection of coronary artery disease. (1989) (24)
- Primary pulmonary hypertension. Current update. (1984) (23)
- Computed tomography of the heart and great vessels: present and future. (1984) (22)
- Familial pulmonary hypertension in association with an abnormal hemoglobin. Insights into the pathogenesis of primary pulmonary hypertension. (1991) (22)
- Relation between hormone replacement therapy in women and coronary artery disease estimated by electron beam tomography. (1997) (22)
- Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart disease. (2011) (21)
- EFFICACY AND SAFETY OF CHRONIC SUBCUTANEOUS INFUSION UT-15 IN PULMONARY ARTERIAL HYPERTENSION (PAH) (ABSTRACT 477) (2000) (20)
- Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension. (2003) (20)
- Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension. (2005) (20)
- The Effects of Vasodilators in Pulmonary Hypertension: Pulmonary Vascular or Peripheral Vascular? (2009) (20)
- Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostacyclin. (1999) (18)
- Pulmonary hypertension: the unaddressed global health burden. (2018) (18)
- Short-term effectiveness of nifedipine in secondary pulmonary hypertension. (1993) (18)
- The potential role for ultrafast cardiac computed tomography in patients with stroke. (1989) (17)
- Erratum: Beraprost therapy for pulmonary arterial hypertension (Journal of the American College of Cardiology (2003) 41 (2119-2125)) (2003) (16)
- The medical treatment of primary pulmonary hypertension. Proven and promising strategies. (1994) (15)
- Targeting pulmonary vascular disease to improve global health: pulmonary vascular disease: the global perspective. (2010) (15)
- Verapamil infusions in the treatment of atrial tachyarrhythmias (1986) (15)
- Evaluation Of Noninvasively Measured Cardiac Output In Patients With Pulmonary Hypertension (2011) (13)
- International Primary Pulmonary Hypertension Study. (1994) (13)
- Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week. (2022) (12)
- Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group. (1989) (12)
- M-mode echocardiography in left bundle branch block: significance of frontal plane QRS axis. (1982) (11)
- The role of thrombosis in pulmonary hypertension. (1993) (11)
- Are anticoagulants still indicated in pulmonary arterial hypertension? (2018) (10)
- A New Classification of Pulmonary Hypertension (2002) (10)
- The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension (2019) (9)
- Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action from the HELP Trial. (2021) (9)
- Severe pulmonary hypertension: critical care clinics. (2001) (9)
- Future of clinical trials for pulmonary hypertension. (2011) (9)
- Serum nifedipine concentrations and response of patients with pulmonary hypertension. (1996) (8)
- A rule for the early detection of chronic changes in cystic fibrosis patient status. (1988) (8)
- Prostacyclin and Primary Pulmonary Hypertension (1994) (7)
- Pulmonary Hypertension The Effects of Chronic Prostacyclin Therapy on Cardiac Output and Symptoms in Primary Pulmonary Hypertension (2016) (7)
- Two dimensional echocardiography of the heart during cardiopulmonary resuscitation in man (1981) (7)
- Acceptance of Transcutaneous Nitroglycerin Patches by Patients with Angina Pectoris (1986) (7)
- Relative adrenal insufficiency in severe congestive heart failure with preserved systolic function: a case report. (2007) (7)
- Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada. (2011) (7)
- Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation. (1998) (6)
- Pulmonary hypertension: Preface (2001) (6)
- Stephen Archer and Stuart Rich ' ' Work in Progress ' ' Primary Pulmonary Hypertension : A Vascular Biology and Translational Research (2000) (6)
- Automated morphologic evaluation of pulmonary arteries in primary pulmonary hypertension. (1986) (6)
- Pulmonary hypertension. (2004) (6)
- Primary pulmonary hypertension: recent advances. (1986) (6)
- Levosimendan‐induced venodilation is mediated by opening of potassium channels (2021) (6)
- Calcium channel blockers for the treatment of primary pulmonary hypertension (1995) (5)
- Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't (2017) (5)
- SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN THE CURRENT ERA: VALIDATION OF THE NATIONAL INSTITUTE OF HEALTH (NIH) RISK STRATIFICATION EQUATION (2007) (4)
- What is pulmonary arterial hypertension? (2012) (4)
- 800-2 Five Year Changes in Coronary Calcification by Ultrafast Computed Tomography (1995) (3)
- Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study (2021) (3)
- Cardiac catheterization in pulmonary hypertension: doing it right, with a catheter on the left. (2020) (3)
- Medical & surgical approaches to pulmonary hypertension. (1997) (3)
- The pulmonary hypertension academic research consortium (2013) (3)
- How do we explain unexplained pulmonary hypertension in the elderly? (2007) (3)
- Primary pulmonary hypertension: modes of diagnosis and aggressive treatment with vasodilators. (1990) (3)
- Dual-Energy Computed Tomography as an Alternative Noninvasive Study for Evaluation of Chronic Thromboembolic Pulmonary Hypertension Postoperatively. (2020) (2)
- 33. NIH Registry on Primary Pulmonary Hypertension: Baseline Characteristics of the Patients Enrolled (1990) (2)
- The Pericardial Effusion Pattern on Phase Images (1984) (2)
- Radionuclide angiography in patients with tricuspid insufficiency (1982) (2)
- Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety (2022) (2)
- ONE YEAR EXPERIENCE WITH INTRAVENOUS TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS (2005) (2)
- The role of late gadolinium enhancement of the right ventricular insertion point predicts survival in patients with pulmonary hypertension (2011) (2)
- Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases (2021) (2)
- Implications of Spontaneous Hemodynamic Variability in Primary Pulmonary-Hypertension (1982) (2)
- Captopril for primary pulmonary hypertension: The problem of variability in assessing chronic drug therapy (1982) (2)
- OUTCOMES OF PULMONARY HYPERTENSION ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (2012) (1)
- PULMONARY VASOREACTIVITY TESTING WITH ADENOSINE PREDICTS LONG TERM HEMODYNAMIC RESPONSE TO PROSTACYCLIN MONOTHERAPY, AND PROSTACYCLIN AND PHOSPHODIESTERASE-5 INHIBITOR COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION (2018) (1)
- The importance of sex in pulmonary hypertension. (2012) (1)
- Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators? (1990) (1)
- Left Ventricular Diastolic Heart Function and Pulmonary Hypertension (2011) (1)
- Vasodilator therapy for pulmonary hypertension. (1980) (1)
- Levosimendan Improves Hemodynamics And Submaximal Exercise Capacity In Ph-hfpef: Primary Results From The Help-ph-hfpef Multicenter Randomized Controlled Trial (2020) (1)
- Epidemiologic and Clinical Characteristics of Primary Pulmonary Hypertension (1987) (1)
- Associated With Connective Tissue Disease Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension (2006) (1)
- A reassessment of the acute hemodynamic effects of vasodilators in primary pulmonary hypertension (1981) (1)
- Abstract 15294: 24-hour Levosimendan Infusion Decreases Biventricular Filling Pressures and Increases Cardiac Output at Rest and Exercise in PH-HFpEF (2020) (1)
- Doppler Echocardiographic Estimates of Pulmonary Artery Systolic Pressure In Patients With Pulmonary Hypertension Are Innacurate (2010) (1)
- The Right Ventricle (2012) (1)
- Novel shunt modification with an adjustable stent‐embedded “fenestrated” septal occluder in a patient with pulmonary hypertension (2019) (1)
- Comprar Textbook Of Pulmonary Vascular Disease | Jason X.-J. Yuan | 9780387874289 | Springer (2011) (0)
- Keynote Lecture : Progress in the Pathophysiology and Treatment of Pulmonary Hypertension (2003) (0)
- Calcium Channel Blockers in the Treatment of Pulmonary Arterial Hypertension (2011) (0)
- Lung Transplantation: Primary pulmonary hypertension: pathophysiology and therapy (2003) (0)
- Abstract 2300: Selective Serotonin Reuptake Inhibitor Use is Associated with Decreased Mortality in Pulmonary Hypertension (2007) (0)
- LATE GADOLINIUM ENHANCEMENT OF THE RIGHT VENTRICULAR INSERTION POINT PREDICTS SURVIVAL IN PATIENTS WITH PULMONARY HYPERTENSION (2011) (0)
- Characteristics of Patients with Pulmonary Hypertension Associated with Left-Sided Heart Failure with Preserved Ejection Fraction. (2009) (0)
- International primary pulmonary hypertension study [1] (1994) (0)
- CORONARY ARTERY CALCIFICATION IS ASSOCIATED WITH VASCULAR ENDOTHELIAL DYSFUNCTION (1999) (0)
- Never Wavering From a Long Commitment to a Cure for PH, Stuart Rich, MD, Aims to Stop the Disease in Its Tracks (2005) (0)
- Sildenafil citrate therapy for pulmonary arterial hypertension (vol 353, pg 2148, 2005) (2006) (0)
- Ultrafast computed tomography: A new method for the evaluation of hypertrophic cardiomyopathy (1987) (0)
- Meeting the Challenge of Surgery and Pulmonary Hypertension: How to Manage the “Hemodynamic Environment” to Optimize Outcomes (2007) (0)
- Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation (1998) (0)
- Recent Advances in Pulmonary Hypertension (2014) (0)
- Primary pulmonary hypertension: Can we meet the challenge? (1985) (0)
- The Effect of Vasodilators on Survival in Primary Pulmonary-Hypertension (1983) (0)
- Treatment of pulmonary arterial hypertension associated with congenital heart disease with intravenous epoprostenol: impact of therapy on timing of transplantation (2002) (0)
- Altered ionized magnesium and calcium in patients with primary pulmonary hypertension (1996) (0)
- Noninvasive Measurement Of Cardiac Output During Exercise In Patients With Pulmonary Hypertension (2012) (0)
- SUCCESS WITH CALCIUM-CHANNEL BLOCKERS IN A PATIENT WHO FAILED BOSENTAN THERAPY FOR IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION (2006) (0)
- Role of Riociguat in the Treatment of Pulmonary Hypertension (2014) (0)
- 35. Mortality Follow-Up of Primary Pulmonary Hypertension (1990) (0)
- The Effect of Vasodilator Therapy on Clinical Outcome in Primary Pulmonary-Hypertension (1983) (0)
- 437: CMR Late Gadolinium Enhancement of the Right Ventricular Insertion Point in Pulmonary Arterial Hypertension (2010) (0)
- Sildenafil And Atorvastatin Added To Bosentan As Therapy For Pulmonary Hypertension (2005) (0)
- Communications to the EditorSitaxsentan in Pulmonary Arterial Hypertension (2003) (0)
- EXPRESS: Prevalence, Incidence, and Survival of Pulmonary Arterial Hypertension: A Systematic Review for the Global Burden of Disease 2020 Study (2021) (0)
- Filling in Patients With Right Ventricular Pressure Overload Due to Primary Pulmonary Hypertension (2010) (0)
- Characteristics of Survival in Primary Pulmonary-Hypertension (1982) (0)
- Prediction of Mortality in Pulmonary Embolism Based on Left Atrial Volume Measurements: Do Indexed Values Matter? (2016) (0)
- Angioscopy and chronic pulmonary arterial obstruction. (1986) (0)
- Pulmonary hypertension and late gadolinium enhancement of the right ventricular insertion point and its clinical implications (2010) (0)
- Coronary artery calcification screening to rule out acute myocardial infarction prior to hospital admission (1996) (0)
- Systemic review of trials using vasodilators in pulmonary arterial hypertension: why a new approac is needed (2010) (0)
- TheShort-term Effects ofDigoxin in Patients WithRight Ventricular Dysfunction FromPulmonary Hypertension* (2015) (0)
- Abstract 1634: A New Risk-Estimation Equation for Predicting Survival in Patients with Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension (2008) (0)
- The Cellular Basis of the Pathophysiology and Treatment of Pulmonary Hypertension (1996) (0)
- Prostacyclin for Secondary Pulmonary Hypertension (2000) (0)
- Incidence and Prognostic Value of Early Repolarization Pattern in the 12-Lead Electrocardiogram (2011) (0)
- The Transition From Chronic Intravenous To Oral Levosimendan Is Safe And Effective In Patients With Pulmonary Hypertension With Heart Failure And Preserved Ejection Fraction (2023) (0)
- 30 DAY RESULTS OF THE SCOUT I STUDY IN PATIENTS WITH SEVERE TRICUSPID REGURGITATION (TR) (2018) (0)
- Diagnosis and Assessment of Non-Pulmonary Arterial Hypertension Masquerading as Idiopathic Pulmonary Arterial Hypertension: Diastolic Heart Failure - Evaluation and Interactions (2008) (0)
- Future Directions: An Expert Panel Explores the Challenge of Halting Progression and Reversing the Pathology of PAH (2003) (0)
- The Use of Calcium Channel Blockers for the Treatment of Primary Pulmonary Hypertension (1990) (0)
- Disease: The Global Perspective Improve Global Health : Pulmonary Vascular Targeting Pulmonary Vascular Disease To (2010) (0)
- Correlations between basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and clinical features of pulmonary arterial hypertension (PAH) (2002) (0)
- Classification of left ventricular hypertrophies (LVH) based on discriminant analysis of time activity curve of equilibrium gated studies (1985) (0)
- Issues facing the conduct of clinical trials in pulmonary hypertension on a global scale (2009) (0)
- ONE-YEAR CHANGES IN RIGHT VENTRICULAR STRAIN FOLLOWING PULMONARY THROMBOENDARTERECTOMY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020) (0)
- ThePrevalence andSignificance ofa PatentForamenOvalein Pulmonary (2015) (0)
- linical Classification of Pulmonary Hypertension (2016) (0)
- Calcium Channel Blockers in the Treatment of Pulmonary Hypertension (2016) (0)
- Unexplained pulmonary hypertension in elderly patients. Editorial (2007) (0)
- What constitutes a beneficial response to vasodilators in pulmonary hypertension (1982) (0)
- Can primary pulmonary hypertension be treated effectively (1994) (0)
- New diastolic filling parameters for evaluation of left ventricular hypertrophies by equilibrium gated studies (1984) (0)
- Clinical Insights IntothePathogenesis ofPrimary Pulmonary Hypertension (2017) (0)
- THE CELLULAR BASIS OF THE PAmOPHYSIOLOGY AND TREATMENT OF PULMONARY HYPERTENSION (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stuart Rich?
Stuart Rich is affiliated with the following schools:
- University of California, Berkeley
- Northwestern University
- University of Illinois College of Medicine
- University of Chicago
- Columbia University
- Washington University in St. Louis
- McGill University
- Imperial College London
- Stanford University
- Johns Hopkins University
- Rush University
- University of Illinois Chicago
- Harvard University